Special NANOTRANSMED conference: Dr. Anil K. PATRI, Director of the Nanotechnology Core Facility of the U.S. Food and Drug Administration
Dr. Anil K. PATRI will explain FDA’s vision on nanomaterials for medecine, currently and in the future, including regulation & toxicity aspects. The conference will be held on September 6th at the Institut de Physique et de Chimie des Matériaux de Strasbourg (IPCMS) from 10.00 to 12.00 and is open and free of charge.
This event is a great opportunity for the NANOTRANSMED consortium, for discussing with Dr. Anil PATRI about future authorizations of clinical testing for the dendronised nano-objects developed in the project and also about possibilities of technology transfer towards the industry.
More information about Dr. Anil K. PATRI here